Ruxrungtham, Kiat |
NCT04505501: Reducing HIV Persistence in Lymph Nodes by Interleukin-15 (IL-15) Receptor Super-agonist (N-803) in Acute HIV Infection |
|
|
| Recruiting | 2 | 15 | RoW | N-803, ALT-803 | Thai Red Cross AIDS Research Centre, Henry M. Jackson Foundation for the Advancement of Military Medicine, Walter Reed Army Institute of Research (WRAIR) | HIV/AIDS | 12/24 | 06/25 | | |
| Completed | 1/2 | 192 | RoW | ChulaCov19 vaccine, Placebo | Chulalongkorn University, Chula Vaccine Research Center (ChulaVRC), Bangkok, Thailand, Center of Excellence in Vaccine Research and Development, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand, Chula Clinical Research Center (Chula CRC), King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand, King Chulalongkorn Memorial Hospital (KCMH), Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand, Center of Excellence for Vaccine Trial (Vaccine Trial Centre), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, National Vaccine Institute, Thailand | COVID-19 Vaccine, Safety Issues | 10/22 | 12/22 | | |
RV582, NCT05769569: Safety and Efficacy of Neutralizing Antibodies and Vaccination for Induction of HIV Remission |
|
|
| Withdrawn | 1 | 35 | RoW | VRC07-523LS, VRC-HIVMAB075-00-AB, PGDM1400LS, N-803, Ad26.Mos4.HIV, MVA-BN-HIV, A244d11 gp120, ALFQ, Antiretroviral Therapy (ART) | Henry M. Jackson Foundation for the Advancement of Military Medicine, US Military HIV Research Program, Janssen Vaccines & Prevention B.V. | HIV-1-infection | 07/25 | 07/25 | | |
NCT01056185: Respiratory Virus Hospitalization Study (FLU 003 Plus) |
|
|
| Completed | N/A | 1000 | Europe, US, RoW | | University of Minnesota, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Clinical & Translational Science Institute, University of Minnesota | Influenza, Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV), Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) | 08/24 | 08/24 | | |
NCT00476606: A Prospective Cohort of Children With HIV Infection |
|
|
| Active, not recruiting | N/A | 500 | RoW | Zidovudine, Stavudine, Didanosine, Lamivudine, Nevirapine, Efavirenz, LPV/r, Saquinavir, Indinavir, Ritonavir, Nelfinavir | The HIV Netherlands Australia Thailand Research Collaboration, Khon Kaen University | HIV Infections | 06/24 | 06/24 | | |
Avihingsanon, Anchalee |
NCT03785106: Tuberculosis Preventive Therapy Among Latent Tuberculosis Infection in HIV-infected Individuals |
|
|
| Active, not recruiting | 3 | 2500 | RoW | Isoniazid/Rifapentine daily (4 weeks) plus pyridoxine (vitamin B6), Isoniazid/Rifapentine 12-weekly plus pyridoxine (vitamin B6) | The HIV Netherlands Australia Thailand Research Collaboration, King Chulalongkorn Memorial Hospital, Police General Hospital, Pranangklao Hospital, Taksin Hospital, Bhumibol Adulyadej Hospital, Klang Hospital, Chiang Rai Prachanukroh Hospital, Sanpatong Hospital, Queen Sawang Vadhana Memorial Hospital, Buddhachinnaraj Hospital, Maharat Nakhon Ratchasima Hospital, HatYai Hospital, Srinagarind Hospital, Khon Kaen University, Sisaket Hospital, The Public Health Centre 28 Krung thon buri | HIV-infected Participants With Latent TB Infection in High TB Burden Country | 03/38 | 03/38 | | |
| Active, not recruiting | 3 | 719 | Japan, US, RoW | Tecovirimat Oral Capsule, Placebo, Tecovirimat Oral Capsule (Open Label) | National Institute of Allergy and Infectious Diseases (NIAID), SIGA Technologies | MPOX | 10/24 | 09/25 | | |
| Recruiting | 3 | 820 | Europe, US, RoW | Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG), Placebo | University of Minnesota, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) | COVID, SARS-CoV2 Infection, Covid19 | 08/26 | 08/26 | | |
NCT05343481: Efficacy of VTP-300 in Chronic Hepatitis B Infection |
|
|
| Active, not recruiting | 2 | 120 | RoW | ChAdOx1-HBV, MVA-HBV, Nivolumab, Opdivo 10mg/ml concentrate for solution for infusion | Barinthus Biotherapeutics | Chronic Hepatitis B | 02/25 | 10/26 | | |
NCT03731559: Efficacy, Safety and Pharmacokinetics of DTG with RIF |
|
|
| Recruiting | 2 | 200 | RoW | DTG 50 mg OD with food, DTG 50 mg BID | The HIV Netherlands Australia Thailand Research Collaboration, Chest Division, Chulalongkorn University, Infectious Disease, Chulalongkorn University, Bamrasnaradura Infectious Diseases Institute, Bhumibol Adulyadej Hospital, Infectious Disease Taksin Hospital, Klang Hospital, Infectious Disease Chiangrai Prachanukroh Hospital, Infectious Disease Chonburi Hospital, Infectious Disease Buddhachinaraj Phitsanulok Hospital, Radboud University Medical Center, Department of Disease Control, Ministry of Public Health (MOPH), Thailand | HIV/TB Coinfection | 06/25 | 06/25 | | |
NCT05330455: Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection |
|
|
| Recruiting | 2 | 132 | Europe, Canada, RoW | GSK3965193, Placebo to match GSK3965193, Bepirovirsen | GlaxoSmithKline | Hepatitis B | 10/27 | 10/27 | | |
NCT05276297 / 2021-003567-10: A Study on the Safety, Efficacy and Immune Response Following Sequential Treatment With an Anti-sense Oligonucleotide Against Chronic Hepatitis B (CHB) and Chronic Hepatitis B Targeted Immunotherapy (CHB-TI) in CHB Patients Receiving Nucleos(t)Ide Analogue (NA) Therapy |
|
|
| Active, not recruiting | 2 | 184 | Europe, RoW | GSK3228836, Bepirovirsen, GSK3528869A, Control | GlaxoSmithKline, GlaxoSmithKline Biologicals | Hepatitis B, Chronic | 02/26 | 02/26 | | |
| Recruiting | 2 | 450 | Europe, Canada, Japan, US, RoW | Bepirovirsen, Placebo | GlaxoSmithKline, GlaxoSmithKline Research & Development Limited | Hepatitis B | 02/29 | 02/29 | | |
NCT03866187 / 2017-001452-55: Safety, Efficacy, Immunogenicity Study of GSK Biologicals' HBV Viral Vector and Adjuvanted Proteins Vaccine (GSK3528869A) in Adult Patients With Chronic Hepatitis B Infection |
|
|
| Terminated | 1/2 | 135 | Europe, RoW | ChAd155-hIi-HBV low dose formulation, ChAd155-hIi-HBV high dose formulation, HBc-HBs/AS01B-4 low dose formulation, HBc-HBs/AS01B-4 high dose formulation, MVA-HBV low dose formulation, MVA-HBV high dose formulation, Placebo | GlaxoSmithKline, GlaxoSmithKline Biologicals | Hepatitis B, Chronic | 10/24 | 10/24 | | |
| Terminated | N/A | 4 | RoW | TST vs PPD microneedle test | The HIV Netherlands Australia Thailand Research Collaboration, National Nanotechnology Center (NANOTEC), The National Science and Technology Development Agency (NSTDA) | Latent Tuberculosis | 10/22 | 10/22 | | |
| Recruiting | N/A | 3152 | RoW | | The HIV Netherlands Australia Thailand Research Collaboration, King Chulalongkorn Memorial Hospital, Thai Red Cross AIDS Research Centre, Siriraj Hospital, Taksin Hospital, Gilead Sciences | HDV | 05/25 | 05/25 | | |
Ananworanich, Jintanat |
NCT01397669: Characteristics of Immunity in Gut Mucosa, Spinal Fluid, Lymph Node and Blood of HIV Negative Thais and Thais with HIV Infection |
|
|
| Recruiting | N/A | 214 | RoW | Colon biopsy, lymph node biopsy, lumbar puncture, Leukapheresis, Brain MRI/MRS/DTI | SEARCH Research Foundation, Armed Forces Research Institute of Medical Sciences, Thailand, Thai Red Cross AIDS Research Centre | HIV-infection | 02/31 | 02/31 | | |
NCT00796146: Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population |
|
|
| Recruiting | N/A | 750 | RoW | | SEARCH Research Foundation, Armed Forces Research Institute of Medical Sciences, Thailand, Thai Red Cross AIDS Research Centre, Yale University, National Institute of Allergy and Infectious Diseases (NIAID), University of California, San Francisco, National Institutes of Health (NIH), Johns Hopkins University, University of Missouri-Columbia | Acute HIV Infection | 07/33 | 07/33 | | |
Sadler, Simon J |
NCT00549367: The Role of Diet Education and Nutritional Counselling in the Ongoing Care of People Living With HIV in Thailand |
|
|
| Completed | N/A | 153 | RoW | Nutrition Counselling | Thai Red Cross AIDS Research Centre, Mahidol University | HIV Infections | 12/22 | 02/23 | | |
Fletcher, James |
NCT04674176: Weight Loss Benefits of Rifaximin in an Intermittent Fasting Diet |
|
|
| Not yet recruiting | 4 | 30 | US | Rifaximin | Bayhealth Medical Center | Weight Loss | 01/22 | 01/22 | | |
Hsu, Denise |
NCT04505501: Reducing HIV Persistence in Lymph Nodes by Interleukin-15 (IL-15) Receptor Super-agonist (N-803) in Acute HIV Infection |
|
|
| Recruiting | 2 | 15 | RoW | N-803, ALT-803 | Thai Red Cross AIDS Research Centre, Henry M. Jackson Foundation for the Advancement of Military Medicine, Walter Reed Army Institute of Research (WRAIR) | HIV/AIDS | 12/24 | 06/25 | | |
Chomchey, Nitiya - |
| Recruiting | 3 | 722 | RoW | HAART, Kivexa, Tivicay | South East Asia Research Collaboration with Hawaii, Thai Red Cross AIDS Research Centre, Pfizer, Gilead Sciences, Merck Sharp & Dohme LLC, ViiV Healthcare | Acute HIV Infection, Chronic HIV Infection | 06/33 | 06/33 | | |
NCT04505501: Reducing HIV Persistence in Lymph Nodes by Interleukin-15 (IL-15) Receptor Super-agonist (N-803) in Acute HIV Infection |
|
|
| Recruiting | 2 | 15 | RoW | N-803, ALT-803 | Thai Red Cross AIDS Research Centre, Henry M. Jackson Foundation for the Advancement of Military Medicine, Walter Reed Army Institute of Research (WRAIR) | HIV/AIDS | 12/24 | 06/25 | | |
CHIMERA, NCT05323695: Implementation of a Depression Screening Intervention at a Transgender Health Clinic in Thailand |
|
|
| Completed | N/A | 317 | RoW | Depression Screening Intervention | Thai Red Cross AIDS Research Centre, amfAR, The Foundation for AIDS Research, National Institutes of Health (NIH), Fogarty International Center of the National Institute of Health | Depressive Symptoms | 02/23 | 07/24 | | |
NCT01397669: Characteristics of Immunity in Gut Mucosa, Spinal Fluid, Lymph Node and Blood of HIV Negative Thais and Thais with HIV Infection |
|
|
| Recruiting | N/A | 214 | RoW | Colon biopsy, lymph node biopsy, lumbar puncture, Leukapheresis, Brain MRI/MRS/DTI | SEARCH Research Foundation, Armed Forces Research Institute of Medical Sciences, Thailand, Thai Red Cross AIDS Research Centre | HIV-infection | 02/31 | 02/31 | | |
| Recruiting | N/A | 50 | RoW | | SEARCH Research Foundation, US Military HIV Research Program | HIV | 03/31 | 03/31 | | |
NCT00796146: Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population |
|
|
| Recruiting | N/A | 750 | RoW | | SEARCH Research Foundation, Armed Forces Research Institute of Medical Sciences, Thailand, Thai Red Cross AIDS Research Centre, Yale University, National Institute of Allergy and Infectious Diseases (NIAID), University of California, San Francisco, National Institutes of Health (NIH), Johns Hopkins University, University of Missouri-Columbia | Acute HIV Infection | 07/33 | 07/33 | | |
Phanuphak, Nittaya |
PALISADE, NCT06134362: Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus) |
|
|
| Recruiting | 3 | 3500 | RoW | CAB LA, Apretude, CAB LA for PrEP | ViiV Healthcare, GlaxoSmithKline, PPD DEVELOPMENT, LP | HIV Infections | 06/28 | 06/28 | | |
NCT06741319: Behavioral and Psychosocial Characteristics of Clients Accessing Services at IHRI |
|
|
| Recruiting | N/A | 300000 | RoW | Demographic characteristics, Social and sexual behaviors, Psychosocial characteristics, Clinical characteristics, Referral and linkage to care for HIV-positive clients, Characteristics associated with service implementation | Institute of HIV Research and Innovation Foundation, Thailand | HIV | 07/27 | 07/30 | | |
NCT03198962: Use of Amphetamine-type Stimulants & Its Relationship With HIV Incidence and Antiretroviral Adherence Among MSM and TG |
|
|
| Completed | N/A | 510 | RoW | | Thai Red Cross AIDS Research Centre, amfAR, The Foundation for AIDS Research, TREAT Asia | HIV Infections | 11/22 | 02/23 | | |
NCT02155231: Study on Anal Human Papillomavirus Infection and Anal Intraepithelial Neoplasia Among Men Who Have Sex With Men in Indonesia, Malaysia, and Thailand |
|
|
| Completed | N/A | 430 | RoW | | Thai Red Cross AIDS Research Centre, Verein Aids Life through TREAT Asia | HPV Testing | 12/20 | 12/22 | | |
NCT03032575: Anal HPV Infection and Risk for Anal High-grade Squamous Intraepithelial Lesion Among Thai MSM With Acute HIV Infection |
|
|
| Completed | N/A | 100 | RoW | SEARCH010/RV254 | Thai Red Cross AIDS Research Centre, SEARCH Research Foundation, amfAR, The Foundation for AIDS Research, TREAT Asia | Human Papillomavirus Infection | 12/22 | 10/23 | | |
NCT03194880: Alere COMBO and Alere q Detect in an HIV PrEP Program in Thailand |
|
|
| Completed | N/A | 150 | RoW | AlereCOMBO and Alere q Detect | Thai Red Cross AIDS Research Centre, Alere, Inc. | HIV | 12/22 | 02/23 | | |
| Completed | N/A | 370 | RoW | questionnaires survey | Thai Red Cross AIDS Research Centre | HIV Infections | 12/21 | 07/22 | | |
NCT04383769: Differentiated Service Delivery for Antiretroviral Therapy |
|
|
| Completed | N/A | 5000 | RoW | questionnaires survey | Thai Red Cross AIDS Research Centre | HIV Infections | 12/21 | 12/23 | | |
NCT04593680: Assessment of Drug-drug Interactions Between Masculinizing Hormone Therapy and Antiretroviral Agents Concomitantly for Pre-exposure Prophylaxis Among Transgender Men |
|
|
| Active, not recruiting | N/A | 20 | RoW | Emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg (F/TDF) and emtricitabine 200 mg/tenofovir alafenamide 25 mg (F/TAF) | Thai Red Cross AIDS Research Centre | Drug Interaction | 10/23 | 10/25 | | |
NCT03580512: Study to Evaluate the Feasibility of Integrating the Point-of-care Testing for Sexually Transmitted Infections and HIV Into Community-based Clinics for MSM and TGW in Thailand |
|
|
| Completed | N/A | 2000 | RoW | | Thai Red Cross AIDS Research Centre | Men Who Have Sex With Men and Transgender Women | 10/22 | 03/24 | | |
| Completed | N/A | 770 | RoW | | Institute of HIV Research and Innovation Foundation, Thailand | HIV | 03/24 | 03/24 | | |
NCT05243030: Developing mHealth to Promote PrEP Use Among Thai Young Men Who Have Sex With Men |
|
|
| Recruiting | N/A | 120 | RoW | Motivational Enhancement System for PrEP Uptake and Adherence (MES-PrEP), Motivational Interactive Text Messaging (MTM), Standard PrEP Counseling | University of Massachusetts, Worcester, National Institute of Mental Health (NIMH), Wayne State University, Institute of HIV Research and Innovation Foundation, Thailand | Pre-Exposure Prophylaxis | 03/25 | 06/25 | | |
| Not yet recruiting | N/A | 154 | RoW | Mobile Healthy Choices (mHC), Finding Respect and Ending Stigma around HIV (FRESH), Standard PrEP Counseling | University of Massachusetts, Worcester, National Institute of Mental Health (NIMH), Institute of HIV Research and Innovation Foundation, Thailand | Pre-Exposure Prophylaxis | 12/26 | 08/27 | | |
| Recruiting | N/A | 450 | RoW | | Institute of HIV Research and Innovation Foundation, Thailand, amfAR, The Foundation for AIDS Research | HIV, STIs, HCV | 05/25 | 05/26 | | |
| Recruiting | N/A | 200 | RoW | KP-Led HCV test and treat service | Institute of HIV Research and Innovation Foundation, Thailand | HCV, HIV | 07/25 | 07/27 | | |
CLYMAX, NCT05559658: Comprehensive Assessment in a Longitudinal Study on Young Men Who Have Sex With Men Attracting to chemseX |
|
|
| Recruiting | N/A | 60 | RoW | | Institute of HIV Research and Innovation Foundation, Thailand, amfAR, The Foundation for AIDS Research | ChemSex Users for YMSM, ChemSex Users | 11/25 | 11/27 | | |
| Recruiting | N/A | 10720 | RoW | In-depth interviews (IDI), Focus group discussion (FGD) | Institute of HIV Research and Innovation Foundation, Thailand, Erasmus Medical Center | Hiv | 12/25 | 12/26 | | |
NCT05262426: Developing mHealth to Promote PrEP Use Among Thai Young Vulnerable Adolescents and Emerging Adults |
|
|
| Recruiting | N/A | 160 | RoW | Behavioral: Motivational Enhancement System for PrEP Uptake and Adherence (MES-PrEP), Enhanced YaCool, Standard PrEP Counseling | University of Massachusetts, Worcester, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Wayne State University, Institute of HIV Research and Innovation Foundation, Thailand | Pre-Exposure Prophylaxis | 12/25 | 07/26 | | |
| Recruiting | N/A | 950 | RoW | OPTIMIZATION PHASE | Institute of HIV Research and Innovation Foundation, Thailand, National Institutes of Health (NIH), amfAR, The Foundation for AIDS Research | Anal High-grade Squamous Intraepithelial Lesion | 12/27 | 12/29 | | |
NCT01397669: Characteristics of Immunity in Gut Mucosa, Spinal Fluid, Lymph Node and Blood of HIV Negative Thais and Thais with HIV Infection |
|
|
| Recruiting | N/A | 214 | RoW | Colon biopsy, lymph node biopsy, lumbar puncture, Leukapheresis, Brain MRI/MRS/DTI | SEARCH Research Foundation, Armed Forces Research Institute of Medical Sciences, Thailand, Thai Red Cross AIDS Research Centre | HIV-infection | 02/31 | 02/31 | | |
| Recruiting | N/A | 50 | RoW | | SEARCH Research Foundation, US Military HIV Research Program | HIV | 03/31 | 03/31 | | |
NCT00796146: Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population |
|
|
| Recruiting | N/A | 750 | RoW | | SEARCH Research Foundation, Armed Forces Research Institute of Medical Sciences, Thailand, Thai Red Cross AIDS Research Centre, Yale University, National Institute of Allergy and Infectious Diseases (NIAID), University of California, San Francisco, National Institutes of Health (NIH), Johns Hopkins University, University of Missouri-Columbia | Acute HIV Infection | 07/33 | 07/33 | | |
Phanuphak, Praphan |
| Recruiting | 3 | 722 | RoW | HAART, Kivexa, Tivicay | South East Asia Research Collaboration with Hawaii, Thai Red Cross AIDS Research Centre, Pfizer, Gilead Sciences, Merck Sharp & Dohme LLC, ViiV Healthcare | Acute HIV Infection, Chronic HIV Infection | 06/33 | 06/33 | | |
| Completed | N/A | 235 | RoW | | Thai Red Cross AIDS Research Centre, ViiV Healthcare, HIV Netherlands Australia Thailand Research Collaboration, Bamrasnaradura Infectious Diseases Institute, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Osteopenia, Vitamin D Deficiency, HIV Infection | 07/21 | 02/23 | | |
| Recruiting | N/A | 10000 | RoW | | The HIV Netherlands Australia Thailand Research Collaboration | HIV Infections | 12/30 | 12/30 | | |
Suttichom, Duanghathai |
| Recruiting | 3 | 722 | RoW | HAART, Kivexa, Tivicay | South East Asia Research Collaboration with Hawaii, Thai Red Cross AIDS Research Centre, Pfizer, Gilead Sciences, Merck Sharp & Dohme LLC, ViiV Healthcare | Acute HIV Infection, Chronic HIV Infection | 06/33 | 06/33 | | |
Vasan, Sandhya |
NCT04505501: Reducing HIV Persistence in Lymph Nodes by Interleukin-15 (IL-15) Receptor Super-agonist (N-803) in Acute HIV Infection |
|
|
| Recruiting | 2 | 15 | RoW | N-803, ALT-803 | Thai Red Cross AIDS Research Centre, Henry M. Jackson Foundation for the Advancement of Military Medicine, Walter Reed Army Institute of Research (WRAIR) | HIV/AIDS | 12/24 | 06/25 | | |
NCT04826094: A Study to Assess the Safety and Immune Response to Env-C DNA and Protein Vaccines in Kenya |
|
|
| Completed | 1 | 126 | RoW | Env-C Plasmid DNA, HIV Env gp145 C.6980 protein, Rehydragel®, ALF43, dmLT, Placebo (IM), Placebo (TCl) | National Institute of Allergy and Infectious Diseases (NIAID), US Army Medical Research Directorate-Africa, US Military HIV Research Program, The Emmes Company, LLC, Walter Reed Army Institute of Research (WRAIR) | HIV Infections | 02/24 | 02/24 | | |
NCT00796146: Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population |
|
|
| Recruiting | N/A | 750 | RoW | | SEARCH Research Foundation, Armed Forces Research Institute of Medical Sciences, Thailand, Thai Red Cross AIDS Research Centre, Yale University, National Institute of Allergy and Infectious Diseases (NIAID), University of California, San Francisco, National Institutes of Health (NIH), Johns Hopkins University, University of Missouri-Columbia | Acute HIV Infection | 07/33 | 07/33 | | |
Trautmann, Lydie |
NCT00796146: Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population |
|
|
| Recruiting | N/A | 750 | RoW | | SEARCH Research Foundation, Armed Forces Research Institute of Medical Sciences, Thailand, Thai Red Cross AIDS Research Centre, Yale University, National Institute of Allergy and Infectious Diseases (NIAID), University of California, San Francisco, National Institutes of Health (NIH), Johns Hopkins University, University of Missouri-Columbia | Acute HIV Infection | 07/33 | 07/33 | | |